Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - November 13

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - 6 days ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - 5 days ago

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - 2 days ago

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - 2 days ago

More Large U.S. Employer Health Plans Covering Weight-Loss Drugs

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs such as Wegovy, Ozempic, and Zepbound.

Business - Inc. - 20 hours ago

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

Science - The New York Times - 6 days ago

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.

Business - CNBC - October 30

Lilly Sues U.S. to Change Hospital Drug Discount Payments

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.

Business - The Wall Street Journal - 5 days ago

Trump Win Could Make Musk’s Robotaxis a Reality, Though Hurdles Remain

Despite the president-elect’s public scorn for EVs, his victory could ease the regulatory path for his billionaire backer’s next big Tesla project.

Business - Inc. - 6 days ago

Joe Flacco to remain Colts starting QB over Anthony Richardson despite throwing 3 INTs in second straight loss

Flacco threw three picks in Sunday's 30-20 loss to Buffalo

Sports - CBS Sports - November 10

Hoping for a weight-loss pill? It could get closer to reality next week.

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.

Business - MarketWatch - November 2

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

Mother-of-two dies during Turkey weight-loss op

Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers

The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.

Business - MarketWatch - 2 hours ago

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - October 30

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS

Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.

Business - CNBC - 5 days ago

Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales forecast higher, as its efforts to offer more personalized care and more ...

Business - MarketWatch - November 5

Control of House remains in limbo as Democrats reflect on losses

Election ballots are still being counted to determine which party will hold the power in the House. Former House Speaker Nancy Pelosi spoke out about the Democratic losses so far. Willie James ...

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.

Business - MarketWatch - November 5

French legislators divided over a lawmaker caught buying drugs

French politicians appear deeply divided over the fate of leftist lawmaker Andy Kerbrat, and whether he should resign

World - ABC News - October 23

Latest in Lilly's weight loss drug shortage deemed over, but hurdles remain